| abstract |
The invention relates to the compounds of formula (1), wherein A, X, Y, Z, Ra, Rb, Rc, R1, R2 and R3 are defined as in claim 1. These compounds are suitable for use in the treatment of diseases which are characterized by excessive or abnormal cell proliferation. The invention also relates to the use of these compounds in the production of a drug having the above-mentioned properties. |